Dr. Edison T. Liu is the president and CEO of The Jackson Laboratory, and the Director of JAX’s NCI Designated Cancer Center. Dr. Liu joined The Jackson Laboratory from the Genome Institute of Singapore as their founding executive director, and chairman of the Health Sciences Authority (FDA equivalent) of Singapore. He was previously the scientific director of the National Cancer Institute’s Division of Clinical Sciences, where he led the intramural clinical translational science programs. Prior to this, Dr. Liu was Professor of Medicine, Biochemistry, Genetics, and Epidemiology at the University of North Carolina at Chapel Hill, and its director for UNC’s Specialized Program of Research Excellence in Breast Cancer. His research focuses on the genomics of human breast cancer, uncovering new oncogenes, the dynamics of gene regulation in cancer biology, and understanding the systems logic of cancer using breast cancer as the model system. Throughout his career, Dr. Liu has received numerous accolades and awards, including the AACR Rosenthal Award and the Brinker International Award, both for breast cancer research; the Public Service Medal from the President of Singapore for his contributions to resolving the SARS crisis; and the Chen Award for Distinguished Academic Achievement in Human Genetics. He was elected to the American Society of Clinical Investigation, as President of the Human Genome Organization (HUGO), as a foreign member of the European Molecular Biology Organization, and as a Fellow of the American Association for the Advancement of Science (AAAS). He holds honorary degrees from Queen’s University (Belfast, Northern Ireland), and Colby College (Maine). He has published more than 340 papers, reviews, and books.
